Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-327636
Filing Date
2020-12-28
Accepted
2020-12-28 16:10:05
Documents
19
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d73593d6k.htm 6-K 12802
2 EX-99.1 d73593dex991.htm EX-99.1 30841
3 EX-99.2 d73593dex992.htm EX-99.2 18128
10 GRAPHIC g73593g05l39.jpg GRAPHIC 9276
11 GRAPHIC g73593g48g07.jpg GRAPHIC 9265
  Complete submission text file 0001193125-20-327636.txt   370055

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT dbvt-20201230.xml EX-101.INS 18097
5 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20201230.xsd EX-101.SCH 6364
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbvt-20201230_cal.xml EX-101.CAL 19375
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20201230_def.xml EX-101.DEF 2488
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20201230_lab.xml EX-101.LAB 48666
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20201230_pre.xml EX-101.PRE 31451
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36697 | Film No.: 201418490
SIC: 2836 Biological Products, (No Diagnostic Substances)